Webinar: How can we assess adherence to a gluten-free diet in coeliac patients?
Coeliac disease affects at least 1 in 100 people in the UK and in Europe,1 and the only way to manage it is through a strict gluten-free diet. However, non-adherence to this diet, whether voluntary or involuntary, is relatively common among coeliac patients, making it challenging for clinicians to determine if other factors are causing symptoms.
Join us for a live webinar on the 20th of January at 1pm, hosted by Ángel Cebolla Ramirez, CEO of Biomedal SL. Ángel will talk about the importance of testing for gluten-free diet adherence using Gluten Immunogenic Peptide (GIP) Tests. These tests detect GIPs in urine or stool to determine whether someone has recently consumed gluten. This allows healthcare teams to objectively monitor and improve adherence to a gluten-free diet, and detect ongoing intestinal damage risk.
Register today to secure your place! CLICK HERE